Heparin and heparan sulfate bind interleukin-10 and modulate its activity

Blood

Volumn 96, Issue 5, 2000, Pages 1879-1888

  Salek Ardakani, Shahram ^a   Arrand, John R ^a   Shaw, David ^a   Mackett, Mike ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; INTERLEUKIN 10;

ARTICLE; BINDING KINETICS; CELL ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; MACROPHAGE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0034284058     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.5.1879     Document Type: Article

References (91)

1. Interleukin-10
2. Interleukin-10
3. Interleukin 10: An overview
4. B-cell-derived IL-10: Production and function
5. Two types of mouse T helper cell, IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
6. Interleukin-10 and its receptor
7. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
8. IL-10, a novel growth cofactor for mature and immature T cells
9. Interleukin 10: A novel stimulatory factor for mast cells and their progenitors
10. Interleukin-10 promotes the growth of megakaryocyte, mast cell, and multilineage colonies: Analysis with committed progenitors and Thy1loSca1 + stem cells
11. Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: Comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts
12. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity: Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10
13. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI
14. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI
15. Heparin structure and interactions with basic fibroblast growth factor
16. Transforming growth factor-beta 1 is a heparin-binding protein: Identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1
17. Molecular modeling of protein-glycosaminoglycan interactions
18. Pattern and spacing of basic amino acids in heparin binding sites
19. Importance of specific amino acids in protein binding sites for heparin and heparan sulfate
20. Glycosaminoglycan-protein interactions: Definition of consensus sites in glycosaminoglycan binding proteins
21. Defining the interleukin-8-binding domain of heparan sulfate
22. Proteoglycans: Structures and interactions
23. Regulated diversity of heparan sulfate
24. The extended family of proteoglycans: Social residents of the pericellular zone
25. Heparan sulphate proteoglycans
26. Structure-activity relationship of heparan sulphate
27. Potential of human polymorphonuclear leukocytes to synthesize and secrete sulfated proteoglycans
28. Chondroitin sulphate proteoglycan production by NK cells and T cells: Effects of xylosides on proliferation and cytotoxic function
29. Proteoglycans synthesized by human polymorphonuclear leucocytes in vitro
30. Distinct patterns of sulfated proteoglycan biosynthesis in human monocytes, granulocytes and myeloid leukemic cells
31. The synthesis of proteoglycans by human T lymphocytes
32. Cell density-dependent expression of chondroitin sulfate proteoglycan in cultured human monocytes
33. Blood platelets stimulate the expression of chondroitin sulfate proteoglycan in human monocytes
34. Relationship between cell adherence and proteoglycan synthesis in cultures of human peripheral blood mononuclear cells: Effects of concanavalin A
35. Modulation of cytokine function by heparan sulfate proteoglycans: Sophisticated models for the regulation of cellular responses to cytokiries
36. Cytokines and proteoglycans
37. Heparan sulphate bound growth factors: A mechanism for stromal cell mediated haemopoiesis
38. Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits
39. Heparan sulphate in the binding and activation of basic fibroblast growth factor
40. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance
41. Interferon-gamma C-terminal function: New working hypothesis: Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate its activity
42. Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence
43. Heparin protects basic and acidic FGF from inactivation
44. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation
45. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
46. Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis
47. The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation
48. Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-gamma
49. Role of glycosaminoglycans (GAGs) in regulation of the immunogenicity of human vascular endothelial cells
50. Endothelial cells: Heparin modulates the induction of functional antigen presentation by IFN-gamma
51. Examination of the mechanism by which heparin antagonizes activation of a model endothelium by interferon-gamma (IFN-gamma)
52. Antigen presentation by endothelium: Heparin reduces the immunogenicity of interferon-gamma-treated endothelial cells
53. Sulfation-dependent down-regulation of interferon-gamma-induced major histocompatibility complex class I and II and intercellular adhesion molecule-1 expression on tubular and endothelial cells by glycosaminoglycans
54. Inhibition of murine L cell interferon action by heparin
55. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
56. Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate
57. A new limulus assay for the detection of endotoxin
58. Isolation of mononuclear cells and granulocytes from human blood: Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g
59. Chlorate: A reversible inhibitor of proteoglycan sulfation
60. Chlorate - A potent inhibitor of protein sulfation in intact cells
61. Two distinct pathways of human macrophage differentiation are mediated by interferon-gamma and interleukin-10
62. Binding Of interferon-γ by glycosaminoglycans: A strategy for localization and/or inhibition of its activity
63. NF-kappa B/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells
64. Growth factors in the extracellular matrix
65. Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes
66. Structural characterization and biological functions of fibroblast growth factor
67. Interaction of hepatocyte growth factor with heparan sulfate: Elucidation of the major heparan sulfate structural determinants
68. Specific binding of the chemokine platelet factor 4 to heparan sulfate
69. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8
70. IL-12 is a heparin-binding cytokine
71. High-affinity binding of interferon-gamma to a basement membrane complex (matrigel)
72. Interferon-gamma binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule
73. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma
74. Heparin affinity of anionic and cationic capillary endothelial cell growth factors: Analysis of hypothalamus-derived growth factors and fibroblast growth factors
75. Characterization of human recombinant interteukin 2 binding to heparin and heparan sulfate using an ELISA approach
76. Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites
77. Regulation of interleukin-8 binding and function by hepatin and alpha2-macroglobulin
78. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific
79. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate
80. Interaction of hepatocyte growth factor with heparan sulfate: Elucidation of the major heparan sulfate structural determinants
81. Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor
82. Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate
83. Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains
84. Glycosaminoglycans mediate cell surface oligomerization of chemokines
85. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses
86. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation
87. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells
88. Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes
89. Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans
90. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity
91. + T lymphocyte migration